Description
An agonist of TrkB (IC50 = 47 nM in a fluorescence anisotropy assay); selectively inhibits BDNF binding to 3T3 cells expressing TrkB over those expressing TrkA, TrkC, or p75NTR; increases survival of hippocampal neurons in vitro, restores neurogenesis and improves cognitive deficits in mouse models of ischemic stroke, Huntington’s disease, Rett syndrome, and a rat model of traumatic brain injury,
Formal name: N1,N3,N5-tris(2-hydroxyethyl)-1,3,5-benzenetricarboxamide
Synonyms:
Molecular weight: 339.3
CAS: 37988-18-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Activators|Kinases||Research Area|Neuroscience|Behavioral Neuroscience|Learning & Memory||Research Area|Neuroscience|Neurodegenerative Disorders|Huntington’s Disease